Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A.sub.3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A.sub.3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.

Docket:RIEM 07-37

Publication/Issued No.:7,867,983

Publication/Issue Date:2011-01-11

Categories: Method

More Detail:Visit USPTO.GOVExternal link


Inventor(s):LIANG, ET AL

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.